Journals – 2015

 

2018   2017   2016    2015    2014    2013    2012    2011    2010    2009     2008     2007    2006    2001-2005    1996-2000    

  

Nigro E, Colavita I, Sarnataro D, Scudiero O, Zambrano G, Granata V, Daniele A, Carotenuto A, Galdiero S, Folliero V, Galdiero M, Urbanowicz RA, Ball JK, Salvatore F, Pessi A. An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule. Sci Rep. 2015; 5:18450.

Falanga A, Galdiero M, Galdiero S. Membranotropic Cell Penetrating Peptides: The Outstanding Journey. Int J Mol Sci. 2015;16(10):25323-37.

Scudiero O, Nigro E, Cantisani M, Colavita I, Leone M, Mercurio FA, Galdiero M, Pessi A, Daniele A, Salvatore F, Galdiero S. Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool. Int J Nanomedicine. 2015;10:6523-39.

Guarnieri D, Biondi M, Yu H, Belli V, Falanga AP, Cantisani M, Galdiero S, Netti PA. Tumor-activated prodrug (TAP)-conjugated nanoparticles with cleavable domains for safe doxorubicin delivery. Biotechnol Bioeng. 2015; 112(3):601-11.

Guarnieri D, Muscetti O, Falanga A, Fusco S, Belli V, Perillo E, Battista E, Panzetta V, Galdiero S,* Netti PA.* Surface decoration with gH625-membranotropic peptides as a method to escape the endo-lysosomal compartment and reduce nanoparticle toxicity. 2015;26(41):415101. *Corresponding authors

Notomista E, Falanga A, Fusco S, Pirone L, Zanfardino A, Galdiero S, Varcamonti M, Pedone E, Contursi P. The identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial molecules. Microb Cell Fact. 2015;14(1):126.

Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, Galdiero M. Silver nanoparticles as potential antibacterial agents. 2015;20(5):8856-74.

Caso JV, Russo L, Palmieri M, Malgieri G, Galdiero S, Falanga A, Isernia C, Iacovino R. Investigating the inclusion properties of aromatic amino acids complexing beta-cyclodextrins in model peptides. Amino Acids. 2015 Oct;47(10):2215-27.

Perillo E, Allard-Vannier E, Falanga A, Stiuso P, Vitiello MT, Galdiero M, Galdiero S,* Chourpa I.* Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells. Int J Pharm. 2015;488(1-2):59-66 *Corresponding authors

Galdiero E, Maselli V, Falanga A, Gesuele R, Galdiero S, Fulgione D, Guida M. Integrated analysis of the ecotoxicological and genotoxic effects of the antimicrobial peptide melittin on Daphnia magna and Pseudokirchneriella subcapitata. Environ Pollut. 2015;203:145-52.

Vitiello G., Falanga A., Petruk A A, Merlino A, Fragneto G, Paduano L, Galdiero S , D’Errico G. Fusion of raft-like lipid bilayers operated by a membranotropic domain of the HSV-type I glycoprotein gH occurs through a cholesterol-dependent mechanism. Soft Matter 2015, 11(15):3003-16.

Borchmann D., Tarallo R., Avendano S., Falanga A., Carberry T., Galdiero S.*, Weck M.* Membranotropic Peptide-Functionalized Poly(lactide)-graft-Poly(ethylene glycol) Brush Copolymers for Intracellular Delivery Macromolecules 2015; 48(4): 942-949.

Galdiero S.*, Falanga A, Berisio R, Grieco P, Morelli G, Galdiero M, Antimicrobial peptides as an opportunity against bacterial diseases. Current Medicinal Chemistry, 2015, 22(14):1665-77. DOI 10.2174/0929867322666150311145632

Ringhieri P., Diaferia C., Galdiero S., Palumbo R., Morelli G., Accardo A., Liposomal doxorubicin doubly functionalized with CCK8 and R8 peptide sequences for selective intracellular drug delivery. Peptide Science, 2015, 21(5):415-25.

Valiante S., Falanga A., Cigliano L., Iachetta G., Busiello R. A., La Marca V., Galdiero M., Lombardi A., Galdiero S. * The peptide gH625 enters into neuron and astrocyte cell lines and crosses the Blood Brain Barrier in rats Int J Nanomedicine. 2015; 10:1885-98. *Corresponding author

Galdiero S.*, Falanga A., Morelli G., Galdiero M. gH625: A milestone in understanding the many roles of membranotropic peptides. Biochim Biophys Acta. 2015;1848(1PA):16-25. *Corresponding author

Guarnieri D., Biondi M., Yu H., Belli V., Falanga A.P., Cantisani M., Galdiero S., Netti P.A. Tumor-activated prodrug (TAP) – conjugated nanoparticles with cleavable domains for safe doxorubicin delivery. Biotechnol Bioeng. 2015;112(3):601-11.